janitrix ['dʒænitriks]

janitrix的基本解释

-

[医] 门静脉

与janitrix相关的网络例句 [注：此内容来源于网络，仅供参考]

Methods A rabbit was celiac-perfused by 5-Fu 100mg/Kg.Then assayed the durg concentrations of janitrix,abdominal aorta,peripheral venous,hydroperitoneum and tissues of liver and kidney by liquid chromatography in specific time;60 cases of hepatocellular carcinoma were radomized into experimental group and placebo group .

实验用家兔腹腔内注入5- Fu 100mg/kg，分别于设定时间抽取门静脉，腹主动脉，外周静脉血，腹腔液，肝、肾组织标本采用高效液相色谱法测定药物浓度；选择中晚期失去手术机会的临床确诊原发性肝癌病人60例，随机分组为实验组（行肝动脉化疗栓塞术中联合腹腔序贯化疗）和对照组（单纯行肝动脉化疗栓塞术）。

Results The drug concentration in the abdoninal cavity was highst,the janitrix was secondary,the abdominal aorta and peripheral venous was the lowest .

结果：腹腔给药后药物在腹腔液中的浓度最高，其峰值浓度是外周静脉血中药物浓度的266.7倍，门静脉其次，约11.3倍，腹主动脉，外周静脉血浓度相仿，为最低。

The drug concentration in the janitrix and the abdoninal cavity is higher than that in the abdoninal aorta and peripheral venous after the treatment.The tissue of liver is about the same to kidney .The durg concentration in the janitrix and tissues is high and invariant for a long time. TACE and sequential chemotherapy inhibit the development of the cancer synergily and the latter cannot induce the toxic reaction.

化疗药物腹腔给药后门静脉血中，腹腔液中药物浓度显著高于腹主动脉，外周静脉血；腹腔给药后，肝组织中药物浓度高于肾组织；药物在门静脉，组织中存在较高的药物浓度，递减缓慢，浓度恒定，维持时间长；肝动脉化疗栓塞术有效地控制了肿瘤的大小，序贯化疗亦有效地抑制了肿瘤的发展和转移，两者间作用相互协同；序贯化疗不增加肿瘤病人的化疗毒副反应。

Passive veno-venous bypass during the anhepatic phase has some benificial effect on alleviating extravasated blood in janitrix system, improving circulation and preventing flora shift in the intestinal tract.

静脉-静脉被动转流在无肝期对减轻门脉系统瘀血，改善肠管血液循环，防止肠道菌群移位等方面有一定作用。